Werewolf Therapeutics CTO Chulani Karunatilake receives $3.9M in 2021
Werewolf Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Werewolf Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, five executives at Werewolf Therapeutics received on average a compensation package of $2.2M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Werewolf Therapeutics
Chulani Karunatilake, Chief Technology Officer, received $3.9M in total. 91% of Karunatilake's compensation, or $3.5M, was in option awards. Karunatilake also received $128K in bonus, $214K in salary, as well as $1.2K in other compensation.
Daniel J. Hicklin, Chief Executive Officer, received a compensation package of $2.5M, which decreased by 18% compared to previous year. 69% of the compensation package, or $1.7M, was in option awards.
Timothy W. Trost, Chief Financial Officer, earned $2.1M in 2021.
Randi Isaacs, Chief Medical Officer, received $1.3M in 2021.
Cynthia Seidel-Dugan, Chief Scientific Officer, earned $1.2M in 2021.
Related executives
Daniel Hicklin
Werewolf Therapeutics
Chief Executive Officer
Timothy Trost
Werewolf Therapeutics
Chief Financial Officer
Chulani Karunatilake
Werewolf Therapeutics
Chief Technology Officer
Randi Isaacs
Werewolf Therapeutics
Chief Medical Officer
Cynthia Seidel-Dugan
Werewolf Therapeutics
Chief Scientific Officer
You may also like
Source: SEC filing on April 22, 2022.